Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Van Spronsen

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 13, 2012
Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989-2008L N van Steenbergen, M Steur, V E P P Lemmens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Improved survival of Hodgkin's patients in south-east Netherlands since 1972D J van Spronsen, I M Dijkema, L W Vrints, et al.
The Netherlands Journal of Medicine|April 9, 2015
The standardised mortality ratio: the proper quality indicator in acute leukaemia?L Saes, W G Peters, R Schaafsma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Treatment and complications in elderly stage III colon cancer patients in the NetherlandsK W J Hoeben, L N van Steenbergen, A J van de Wouw, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2011
Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the NetherlandsK K H Aben, S Heskamp, M L Janssen-Heijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphomaS A M van de Schans, A N M Wymenga, D J van Spronsen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2014
Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?F N van Erning, L N van Steenbergen, V E P P Lemmens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2013
Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the NetherlandsM L G Janssen-Heijnen, L N van Steenbergen, A C Voogd, et al.
British Journal of Cancer|October 7, 2010
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patientsW J Lesterhuis, I J M de Vries, E A Aarntzen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerB E P J Vriens, M J B Aarts, B de Vries, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|September 13, 2012
Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989-2008L N van Steenbergen, M Steur, V E P P Lemmens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Improved survival of Hodgkin's patients in south-east Netherlands since 1972D J van Spronsen, I M Dijkema, L W Vrints, et al.
The Netherlands Journal of Medicine|April 9, 2015
The standardised mortality ratio: the proper quality indicator in acute leukaemia?L Saes, W G Peters, R Schaafsma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Treatment and complications in elderly stage III colon cancer patients in the NetherlandsK W J Hoeben, L N van Steenbergen, A J van de Wouw, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2011
Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the NetherlandsK K H Aben, S Heskamp, M L Janssen-Heijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphomaS A M van de Schans, A N M Wymenga, D J van Spronsen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2014
Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?F N van Erning, L N van Steenbergen, V E P P Lemmens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2013
Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the NetherlandsM L G Janssen-Heijnen, L N van Steenbergen, A C Voogd, et al.
British Journal of Cancer|October 7, 2010
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patientsW J Lesterhuis, I J M de Vries, E A Aarntzen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerB E P J Vriens, M J B Aarts, B de Vries, et al.
Pageof 4